Holen Sie sich die Stockscreener-App
1.57
5.99%
-0.10
Handel nachbörslich:
1.60
0.03
+1.91%
Schlusskurs vom Vortag:
$1.67
Offen:
$1.65
24-Stunden-Volumen:
70,668
Relative Volume:
0.06
Marktkapitalisierung:
$16.93M
Einnahmen:
$144.00K
Nettoeinkommen (Verlust:
$-14.50M
KGV:
-1.0827
EPS:
-1.4501
Netto-Cashflow:
$-14.95M
1W Leistung:
-13.26%
1M Leistung:
-36.44%
6M Leistung:
-69.16%
1J Leistung:
-66.52%
1-Tages-Spanne:
$1.55
$1.66
1-Wochen-Bereich:
$1.55
$1.81
52-Wochen-Spanne:
$1.5341
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Firmenname
Serina Therapeutics Inc
Sektor
Branche
Telefon
(256) 327-9630
Adresse
601 GENOME WAY, HUNTSVILLE
Compare SER vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
1.57 | 18.01M | 144.00K | -14.50M | -14.95M | -1.4501 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-14 | Eingeleitet | H.C. Wainwright | Buy |
Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten
Serina Therapeutics Advances SER-252 Parkinson’s Trial, Marking a Key Early Milestone for Investors - TipRanks
Entry Recap: Is Zillow Group Inc showing insider buying2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Serina Therapeutics Announces Dosing of First Patient in - GlobeNewswire
New drug SER-252 enters Phase 1b trial for advanced Parkinson's - Stock Titan
SER SEC FilingsSerina Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Serina Therapeutics2026 Funding Rounds & List of Investors - Tracxn
Serina Begins Phase 1b Registrational Trial Of SER-252 In Advanced Parkinson's - Nasdaq
First patient enrolled in Serina’s Parkinson’s disease trial - Investing.com
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease - The Manila Times
New Parkinson's trial enrolls first patient as Serina targets advanced disease - Stock Titan
SER PE Ratio & Valuation, Is SER Overvalued - Intellectia AI
Serina Therapeutics (SER) SVP awarded 69,000 stock options at $2.76 - Stock Titan
What are Serina Therapeutics Inc.’s recent SEC filings showingWeekly Loss Report & Fast Momentum Entry Tips - mfd.ru
Momentum Shift: Is CERo Therapeutics Holdings Inc likely to announce a buybackMarket Movers & High Accuracy Swing Trade Signals - baoquankhu1.vn
Aug Drivers: Whats next for Marchex Inc stockShort Setup & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Is Serina Therapeutics Inc. benefiting from interest rate changesTrade Performance Summary & Technical Entry and Exit Tips - mfd.ru
Will Serina Therapeutics Inc. stock outperform international peersJuly 2025 Big Picture & Expert Approved Momentum Trade Ideas - mfd.ru
Published on: 2026-02-05 05:58:49 - mfd.ru
Serina Therapeutics CSO sells $19,680 in shares By Investing.com - Investing.com South Africa
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event - The Globe and Mail
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event - Finviz
Bull Bear: Is Serina Therapeutics Inc a stock for growth or value investorsTrade Entry Summary & Smart Swing Trading Techniques - baoquankhu1.vn
Stock Recap: Is Serina Therapeutics Inc a stock for growth or value investorsEarnings Performance Report & High Conviction Investment Ideas - baoquankhu1.vn
Serina Therapeutics Insider Sells $23K in Stock - National Today
Why did SER stock surge over 70% in pre-market today? - MSN
Bull Run: What are Serina Therapeutics Incs recent SEC filings showingMarket Growth Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
Serina Therapeutics CSO sells $23,185 in shares By Investing.com - Investing.com Canada
Serina Therapeutics CSO sells $23,185 in shares - Investing.com
Serina Therapeutics Stock Soars Amid Strategic Partnership Announcements - StocksToTrade
Serina Therapeutics Announces FDA Clearance of IND - GlobeNewswire
Serina Jumps On FDA's IND Clearance For SER-252 In Advanced Parkinson's Disease After Clinical Hold - Nasdaq
What Sparked Serina Therapeutics (SER) 35% After-Hours Surge? - Finviz
Serina Therapeutics stock soars after FDA clears IND for Parkinson’s drug By Investing.com - Investing.com South Africa
Serina Therapeutics stock soars after FDA clears IND for Parkinson’s drug - Investing.com UK
Serina Therapeutics announces FDA clearance of IND application for SER-252 for the treatment of advanced Parkinson's disease - marketscreener.com
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease - The Manila Times
Serina Therapeutics, Inc. Announces FDA Clearance for SER-252 IND - TradingView
FDA clears trial of new advanced Parkinson’s therapy SER-252 - stocktitan.net
New Highs: Why is Serina Therapeutics Inc stock going upJuly 2025 Update & Weekly Breakout Stock Alerts - baoquankhu1.vn
Serina Therapeutics CSO sells $7375 in shares By Investing.com - Investing.com Canada
Aug Technicals: Is Serina Therapeutics Inc benefiting from innovation trends2025 Biggest Moves & Daily Growth Stock Investment Tips - baoquankhu1.vn
Serina Therapeutics CSO sells $12,140 in shares By Investing.com - Investing.com UK
Serina Therapeutics CSO sells $12,140 in shares - Investing.com
Geopolitics Watch: Why is Serina Therapeutics Inc stock going upTrade Risk Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
Winners Losers: What is the dividend yield of Serina Therapeutics IncJuly 2025 Action & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Serina Therapeutics receives NYSE notification - MSN
Serina Therapeutics (SER) Receives NYSE Deficiency Notice for Low Stockholders' Equity - Intellectia AI
Serina Therapeutics Receives NYSE Deficiency Notice; Stock Edges Down - Nasdaq
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity - The Globe and Mail
Serina Therapeutics receives NYSE listing deficiency notice - Investing.com
Finanzdaten der Serina Therapeutics Inc-Aktie (SER)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
Kapitalisierung:
|
Volumen (24h):